Novacyt (NCYT)

Currency in GBP
42.20
-2.80(-6.22%)
Closed·
NCYT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
NCYT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
41.0043.10
52 wk Range
36.10137.00
Key Statistics
Bid/Ask
41.60 / 45.00
Prev. Close
45
Open
43.1
Day's Range
41-43.1
52 wk Range
36.1-137
Volume
125.55K
Average Volume (3m)
78.44K
1-Year Change
-18.85%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NCYT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Novacyt News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Novacyt Company Profile

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.

Compare NCYT to Peers and Sector

Metrics to compare
NCYT
Peers
Sector
Relationship
P/E Ratio
−0.8x−2.5x−0.5x
PEG Ratio
0.020.010.00
Price/Book
0.6x1.9x2.6x
Price / LTM Sales
1.5x4.7x3.3x
Upside (Analyst Target)
-104.3%40.6%
Fair Value Upside
Unlock1.0%5.3%Unlock

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NCYT Income Statement

People Also Watch

22.11
STMPA
-0.36%
4.412
VLS
-6.13%
26.64
DAST
-0.49%
1.9320
IPH
+1.68%
237.50
TCFP
+2.55%

FAQ

What Stock Exchange Does Novacyt Trade On?

Novacyt is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Novacyt?

The stock symbol for Novacyt is "NCYT."

What Is the Novacyt Market Cap?

As of today, Novacyt market cap is 29.75M.

What Is Novacyt's Earnings Per Share (TTM)?

The Novacyt EPS (TTM) is -0.55.

When Is the Next Novacyt Earnings Date?

Novacyt will release its next earnings report on 24 Sept 2025.

From a Technical Analysis Perspective, Is NCYT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Novacyt Stock Split?

Novacyt has split 0 times.

How Many Employees Does Novacyt Have?

Novacyt has 234 employees.

What is the current trading status of Novacyt (NCYT)?

As of 15 Aug 2025, Novacyt (NCYT) is trading at a price of 42.20, with a previous close of 45.00. The stock has fluctuated within a day range of 41.00 to 43.10, while its 52-week range spans from 36.10 to 137.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.